comparemela.com
Home
Live Updates
Avance Clinical: Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner : comparemela.com
Avance Clinical: Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
Affecting Drug Development Schedules and Financial Plans SAN FRANCISCO, CA, Jan 9, 2024 - (ACN Newswire) - Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US
Related Keywords
Australia ,
China ,
New Zealand ,
United States ,
Australian ,
American ,
Yvonne Lungershausen ,
Sullivan Asia Pacific ,
Drug Development Schedules ,
Oracle ,
Globalready Site Partnership Program ,
North American ,
Artificial Intelligence ,
Machine Learning ,
Avance Clinical ,
Biotech Showcase ,
Practices Leadership ,
Leadership Award ,
Australian Government ,
comparemela.com © 2020. All Rights Reserved.